Literature DB >> 23071295

CCN1 expression in hepatocytes contributes to macrophage infiltration in nonalcoholic fatty liver disease in mice.

Zhaolian Bian1, Yanshen Peng, Zhengrui You, Qixia Wang, Qi Miao, Yuan Liu, Xiaofeng Han, Dekai Qiu, Zhiping Li, Xiong Ma.   

Abstract

Our objective was to investigate the potential roles of CCN1 in the inflammation and macrophage infiltration of nonalcoholic fatty liver disease (NAFLD). The regulation of hepatic CCN1 expression was investigated in vitro with murine primary hepatocytes treated with free fatty acids or lipopolysaccharide (LPS) and in vivo with high-fat (HF) diet-fed mice or ob/ob mice. CCN1 protein and a liver-specific CCN1 expression plasmid were administered to mice fed a normal diet (ND) or HF diet. Myeloid-derived macrophages and RAW264.7 cells were also treated with CCN1 in vitro to determine the chemotactic effects of CCN1 on macrophages. LPS treatment significantly increased hepatic CCN1 expression in HF diet-fed mice and ob/ob mice. LPS and FFAs induced CCN1 expression in primary murine hepatocytes in vitro through the TLR4/MyD88/AP-1 pathway. CCN1 protein and overexpression of CCN1 in the liver induced more severe hepatic inflammation and macrophage infiltrates in HF mice than in ND mice. CCN1 recruited macrophages through activation of the Mek/Erk signaling pathway in myeloid-derived macrophages and RAW264.7 cells in vitro. Endotoxin and FFA-induced CCN1 expression in hepatocytes is involved in the hepatic proinflammatory response and macrophage infiltration in murine NAFLD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23071295      PMCID: PMC3520538          DOI: 10.1194/jlr.M026013

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  32 in total

1.  The human growth factor-inducible immediate early gene, CYR61, maps to chromosome 1p.

Authors:  P Jay; J L Bergé-Lefranc; C Marsollier; C Méjean; S Taviaux; P Berta
Journal:  Oncogene       Date:  1997-04-10       Impact factor: 9.867

2.  Identification of integrin alpha(M)beta(2) as an adhesion receptor on peripheral blood monocytes for Cyr61 (CCN1) and connective tissue growth factor (CCN2): immediate-early gene products expressed in atherosclerotic lesions.

Authors:  Joseph M Schober; Ningyu Chen; Tatiana M Grzeszkiewicz; Igor Jovanovic; Eugene E Emeson; Tatiana P Ugarova; Richard D Ye; Lester F Lau; Stephen C-T Lam
Journal:  Blood       Date:  2002-06-15       Impact factor: 22.113

3.  Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease.

Authors:  Zhiping Li; Mark J Soloski; Anna Mae Diehl
Journal:  Hepatology       Date:  2005-10       Impact factor: 17.425

Review 4.  Nonalcoholic fatty liver disease: from steatosis to cirrhosis.

Authors:  Geoffrey C Farrell; Claire Z Larter
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

5.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

Authors:  David E Kleiner; Elizabeth M Brunt; Mark Van Natta; Cynthia Behling; Melissa J Contos; Oscar W Cummings; Linda D Ferrell; Yao-Chang Liu; Michael S Torbenson; Aynur Unalp-Arida; Matthew Yeh; Arthur J McCullough; Arun J Sanyal
Journal:  Hepatology       Date:  2005-06       Impact factor: 17.425

Review 6.  Nonalcoholic steatohepatitis.

Authors:  Elizabeth M Brunt
Journal:  Semin Liver Dis       Date:  2004-02       Impact factor: 6.115

Review 7.  CCN proteins: multifunctional signalling regulators.

Authors:  Bernard Perbal
Journal:  Lancet       Date:  2004-01-03       Impact factor: 79.321

8.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

Authors:  A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

9.  Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway.

Authors:  Ariel E Feldstein; Nathan W Werneburg; Ali Canbay; Maria Eugenia Guicciardi; Steven F Bronk; Robert Rydzewski; Laurence J Burgart; Gregory J Gores
Journal:  Hepatology       Date:  2004-07       Impact factor: 17.425

10.  Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice.

Authors:  Ariel E Feldstein; Ali Canbay; Maria E Guicciardi; Hajime Higuchi; Steven F Bronk; Gregory J Gores
Journal:  J Hepatol       Date:  2003-12       Impact factor: 25.083

View more
  23 in total

1.  Aerobic exercise training in the treatment of non-alcoholic fatty liver disease related fibrosis.

Authors:  Melissa A Linden; Ryan D Sheldon; Grace M Meers; Laura C Ortinau; E Matthew Morris; Frank W Booth; Jill A Kanaley; Victoria J Vieira-Potter; James R Sowers; Jamal A Ibdah; John P Thyfault; M Harold Laughlin; R Scott Rector
Journal:  J Physiol       Date:  2016-05-27       Impact factor: 5.182

Review 2.  Immune Cell Trafficking to the Liver.

Authors:  Sulemon Chaudhry; Jean Emond; Adam Griesemer
Journal:  Transplantation       Date:  2019-07       Impact factor: 4.939

Review 3.  Matricellular protein CCN1/CYR61: a new player in inflammation and leukocyte trafficking.

Authors:  Yalin Emre; Beat A Imhof
Journal:  Semin Immunopathol       Date:  2014-03-18       Impact factor: 9.623

4.  The role of CCN family genes in haematological malignancies.

Authors:  J E Wells; M Howlett; L C Cheung; Ursula R Kees
Journal:  J Cell Commun Signal       Date:  2015-05-31       Impact factor: 5.782

5.  Spinal cord injury causes chronic liver pathology in rats.

Authors:  Andrew D Sauerbeck; J Lukas Laws; Veera V R Bandaru; Phillip G Popovich; Norman J Haughey; Dana M McTigue
Journal:  J Neurotrauma       Date:  2014-10-21       Impact factor: 5.269

6.  Role of cysteine-rich 61 protein (CCN1) in macrophage-mediated oncolytic herpes simplex virus clearance.

Authors:  Amy Haseley Thorne; Walter H Meisen; Luke Russell; Ji Young Yoo; Chelsea M Bolyard; Justin D Lathia; Jeremy Rich; Vinay K Puduvalli; Hsiaoyin Mao; Jianhua Yu; Michael A Caligiuri; Susheela Tridandapani; Balveen Kaur
Journal:  Mol Ther       Date:  2014-06-04       Impact factor: 11.454

7.  Treatment of cholestatic fibrosis by altering gene expression of Cthrc1: Implications for autoimmune and non-autoimmune liver disease.

Authors:  Zhaolian Bian; Qi Miao; Wei Zhong; Haiyan Zhang; Qixia Wang; Yanshen Peng; Xiaoyu Chen; Canjie Guo; Li Shen; Fan Yang; Jie Xu; Dekai Qiu; Jingyuan Fang; Scott Friedman; Ruqi Tang; M Eric Gershwin; Xiong Ma
Journal:  J Autoimmun       Date:  2015-08-01       Impact factor: 7.094

8.  Hepatocyte Stress Increases Expression of Yes-Associated Protein and Transcriptional Coactivator With PDZ-Binding Motif in Hepatocytes to Promote Parenchymal Inflammation and Fibrosis.

Authors:  Meghan Mooring; Brendan H Fowl; Shelly Z C Lum; Ye Liu; Kangning Yao; Samir Softic; Rory Kirchner; Aaron Bernstein; Aatur D Singhi; Daniel G Jay; C Ronald Kahn; Fernando D Camargo; Dean Yimlamai
Journal:  Hepatology       Date:  2020-01-03       Impact factor: 17.425

9.  A dietary ketone ester mitigates histological outcomes of NAFLD and markers of fibrosis in high-fat diet fed mice.

Authors:  Mary P Moore; Rory P Cunningham; Rachel A H Davis; Sarah E Deemer; Brandon M Roberts; Eric P Plaisance; R Scott Rector
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-01-27       Impact factor: 4.052

10.  Cyr61 promotes CD204 expression and the migration of macrophages via MEK/ERK pathway in esophageal squamous cell carcinoma.

Authors:  Manabu Shigeoka; Naoki Urakawa; Mari Nishio; Nobuhisa Takase; Soken Utsunomiya; Hiroaki Akiyama; Yoshihiro Kakeji; Takahide Komori; Yu-ichiro Koma; Hiroshi Yokozaki
Journal:  Cancer Med       Date:  2015-01-26       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.